<DOC>
	<DOC>NCT00534547</DOC>
	<brief_summary>The purpose of this study is to investigate the role of an experimental surgery that may offer better short and long-term control of T2DM in select patients who have not achieved adequate blood sugar control with regular means.</brief_summary>
	<brief_title>Duodenal Exclusion for the Treatment of Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>Inclusion criteria: Age between 20 and 50 years old; BMI between 27 and 34.9; Oral agents or insulin to control T2DM; Inadequate control of diabetes as defined as HbA1c&gt;8.0% but &lt;10% Understanding of the mechanisms of action of the treatment Exclusion criteria: More than 5 years of T2DM diagnosis; Cpeptide &lt;1pg/ml (off insulin) Previous abdominal operations; History of gastritis History of GERD History of peptic ulcer disease Inflammatory bowel disease Coagulopathy; Liver cirrhosis; Unable to comply with study requirements, followup schedule or give valid informed consent; Currently pregnant (pregnancy test required for confirmation for those of child bearing years) Patient is not available for programmed followup during the study period Patient is unwilling to forgo good samaritan blood donation during the study period</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>